Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth-Metronidazole Triple vs Quadruple Therapy for H. pylori
NCT04667299Phase 4Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole, bismuth subcitrate, metronidazole in Helicobacter pylori infection, sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
rabeprazolebismuth subcitratemetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04667299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04667299.